<DOC>
	<DOCNO>NCT00609193</DOCNO>
	<brief_summary>The purpose study use magnetic resonance imaging ( MRI ) examine brain structure , function chemistry people bipolar disorder treat either quetiapine lithium . Both medicine FDA-approved treat mania adult lithium also FDA approve child ; quetiapine commonly use child mania , FDA approve indication age group .</brief_summary>
	<brief_title>Functional Neurochemical Brain Changes First-episode Bipolar Mania</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Inclusion Criteria Firstepisode manic bipolar patient ( N=100 ; 1520 patients/year ) : 1 . Patients meet DSMIV criterion type I bipolar disorder , manic mixed . 2 . Patients index Young Mania Rating Scale ( YMRS ) 70 total score &gt; 20 . 3 . Patients &lt; 3 month lifetime antimanic antidepressant medication exposure , include active psychotropic medication one week prior index admission . Importantly , patient NOT take medication study ; criterion exclude subject receive active treatment time admission support 'firstepisode ' criterion . 4 . Patients two prior episode major depression . 5 . Patients 12 35 year old ; subject &lt; 18 yr old Tanner great equal 4 Exclusion criterion : All subject exclude participation follow reason . 1 . Any chemical use disorder within 3 month . 2 . Any medical neurological disorder could influence fMRI MRS result . 3 . A history mental retardation estimate IQ total score &lt; 85 . 4 . An MRI scan contraindicate subject . 5 . The patient attend followup visit . 6 . A positive urine pregnancy test ( woman ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>